130 related articles for article (PubMed ID: 12883526)
21. Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model.
Li J; Simeoni E; Fleury S; Dudler J; Fiorini E; Kappenberger L; von Segesser LK; Vassalli G
Eur J Cardiothorac Surg; 2006 May; 29(5):779-83. PubMed ID: 16520057
[TBL] [Abstract][Full Text] [Related]
22. Suppression of experimental crescentic glomerulonephritis by interleukin-10 gene transfer.
El-Shemi AG; Fujinaka H; Matsuki A; Kamiie J; Kovalenko P; Qu Z; Bilim V; Nishimoto G; Yaoita E; Yoshida Y; Anegon I; Yamamoto T
Kidney Int; 2004 Apr; 65(4):1280-9. PubMed ID: 15086467
[TBL] [Abstract][Full Text] [Related]
23. Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis.
Kitching AR; Tipping PG; Timoshanko JR; Holdsworth SR
Kidney Int; 2000 Feb; 57(2):518-25. PubMed ID: 10652028
[TBL] [Abstract][Full Text] [Related]
24. Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees.
Lechman ER; Jaffurs D; Ghivizzani SC; Gambotto A; Kovesdi I; Mi Z; Evans CH; Robbins PD
J Immunol; 1999 Aug; 163(4):2202-8. PubMed ID: 10438962
[TBL] [Abstract][Full Text] [Related]
25. A superagonistic monoclonal antibody for CD28 ameliorates crescentic glomerulonephritis in wistar-kyoto rats.
Takabatake Y; Li XK; Mizui M; Miyasato K; Matsui I; Kawada N; Imai E; Hünig T; Takahara S; Wada T; Furuichi K; Rakugi H; Isaka Y
Mol Med; 2011; 17(7-8):686-96. PubMed ID: 21487638
[TBL] [Abstract][Full Text] [Related]
26. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
[TBL] [Abstract][Full Text] [Related]
27. Intravenous delivery of naked plasmid DNA for in vivo cytokine expression.
Jiang J; Yamato E; Miyazaki J
Biochem Biophys Res Commun; 2001 Dec; 289(5):1088-92. PubMed ID: 11741303
[TBL] [Abstract][Full Text] [Related]
28. Combined CD4+ Th1 effect and lymphotactin transgene expression enhance CD8+ Tc1 tumor localization and therapy.
Huang H; Bi XG; Yuan JY; Xu SL; Guo XL; Xiang J
Gene Ther; 2005 Jun; 12(12):999-1010. PubMed ID: 15789061
[TBL] [Abstract][Full Text] [Related]
29. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis.
Khan SB; Cook HT; Bhangal G; Smith J; Tam FW; Pusey CD
Kidney Int; 2005 May; 67(5):1812-20. PubMed ID: 15840028
[TBL] [Abstract][Full Text] [Related]
30. Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1).
Wada T; Yokoyama H; Furuichi K; Kobayashi KI; Harada K; Naruto M; Su SB; Akiyama M; Mukaida N; Matsushima K
FASEB J; 1996 Oct; 10(12):1418-25. PubMed ID: 8903512
[TBL] [Abstract][Full Text] [Related]
31. Adenovirus-mediated interleukin-13 gene therapy attenuates acute kidney allograft injury.
Sandovici M; Deelman LE; van Goor H; Helfrich W; de Zeeuw D; Henning RH
J Gene Med; 2007 Dec; 9(12):1024-32. PubMed ID: 17902182
[TBL] [Abstract][Full Text] [Related]
32. Decoy receptor 3 ameliorates an autoimmune crescentic glomerulonephritis model in mice.
Ka SM; Sytwu HK; Chang DM; Hsieh SL; Tsai PY; Chen A
J Am Soc Nephrol; 2007 Sep; 18(9):2473-85. PubMed ID: 17687076
[TBL] [Abstract][Full Text] [Related]
33. Inducible co-stimulatory molecule ligand is protective during the induction and effector phases of crescentic glomerulonephritis.
Odobasic D; Kitching AR; Semple TJ; Holdsworth SR
J Am Soc Nephrol; 2006 Apr; 17(4):1044-53. PubMed ID: 16540559
[TBL] [Abstract][Full Text] [Related]
34. Gene transfer of Fc-fusion cytokine by in vivo electroporation: application to gene therapy for viral myocarditis.
Adachi O; Nakano A; Sato O; Kawamoto S; Tahara H; Toyoda N; Yamato E; Matsumori A; Tabayashi K; Miyazaki J
Gene Ther; 2002 May; 9(9):577-83. PubMed ID: 11973633
[TBL] [Abstract][Full Text] [Related]
35. Electroporation-mediated transfer of plasmid DNA encoding IL-10 attenuates orthotopic tracheal allograft stenosis in rats.
Tsuchida M; Koike T; Takekubo M; Hirahara H; Hanawa H; Maruyama H; Miyazaki J; Hayashi J
Transpl Immunol; 2008 Jul; 19(3-4):173-7. PubMed ID: 18572408
[TBL] [Abstract][Full Text] [Related]
36. Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat.
Reynolds J; Prodromidi EI; Juggapah JK; Abbott DS; Holthaus KA; Kalluri R; Pusey CD
J Am Soc Nephrol; 2005 May; 16(5):1350-9. PubMed ID: 15814836
[TBL] [Abstract][Full Text] [Related]
37. Post-secretion neutralization of transgene-derived effect: soluble erythropoietin receptor/IgG1Fc expressed in liver neutralizes erythropoietin produced in muscle.
Maruyama H; Higuchi M; Higuchi N; Kameda S; Saito M; Sugawa M; Matsuzaki J; Neichi T; Yokoyama S; Miyazaki Y; Miyazaki J; Gejyo F
J Gene Med; 2004 Feb; 6(2):228-37. PubMed ID: 14978776
[TBL] [Abstract][Full Text] [Related]
38. Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice.
Ka SM; Huang XR; Lan HY; Tsai PY; Yang SM; Shui HA; Chen A
J Am Soc Nephrol; 2007 Jun; 18(6):1777-88. PubMed ID: 17475816
[TBL] [Abstract][Full Text] [Related]
39. Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice.
Koh JJ; Ko KS; Lee M; Han S; Park JS; Kim SW
Gene Ther; 2000 Dec; 7(24):2099-104. PubMed ID: 11223991
[TBL] [Abstract][Full Text] [Related]
40. Endogenous Tim-1 (Kim-1) promotes T-cell responses and cell-mediated injury in experimental crescentic glomerulonephritis.
Nozaki Y; Nikolic-Paterson DJ; Snelgrove SL; Akiba H; Yagita H; Holdsworth SR; Kitching AR
Kidney Int; 2012 May; 81(9):844-55. PubMed ID: 22205357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
